ScholarIQanswers from OpenAlex

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study

PaperCitations, authors & open-access status

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study have?

ScholarIQcitation count

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study has 102 citations in the OpenAlex counts ScholarIQ stores.

When was Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study published?

ScholarIQyear

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study has 2000 year in the ScholarIQ index.

What is the open-access status of Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study?

ScholarIQoa status

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study has closed oa status in the ScholarIQ index.

What is the DOI of Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study?

ScholarIQdoi

The DOI for Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study is on the source record.

What is the PMID of Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study?

ScholarIQpmid

The PMID for Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study is on the source record.

What is the OpenAlex record for Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study?

ScholarIQopenalex

The OpenAlex for Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial